Ascensia Diabetes Care is a global medical device company headquartered in Basel, Switzerland. The mission statement of the company is to improve the lives of diabetes patients, with a specific emphasis on changing patient behavior. The company has 1,700 employees, and over 10 million diabetes patients.
Ascensia came up with the idea of an international competition for startups with innovative products for the diabetes market. The Ascensia Diabetes Challenge kicked off earlier this year, accepting submissions from nearly 120 startups and entrepreneurs around the world outlining unique digital solutions and strategies and mobile intervention to improve outcomes for patients with type 2 diabetes.
Dr. Price Kerfoot submitted Qstream’s diabetes intervention into the competition, the efficacy of which was proved in a randomized trial of 456 patients of the eastern seaboard of US.
We are very excited to announce that Qstream has been named one of six finalists in the challenge!
The next step is for Dr. Kerfoot and Qstream to present our solution at finalist event on April 19 at Ascensia Diabetes Care Global HQ in Basel, Switzerland. The winning solution will be announced at the American Diabetes Association’s 78th Scientific Sessions in June.
Read the full press release here.
Congratulations and best wishes to all the finalists!
Keep up to date with Qstream Healthcare, follow us on Twitter @QstreamCME.